BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8505497)

  • 1. Transient focal hepatic defects related to sustained-release niacin.
    Lawrence SP
    J Clin Gastroenterol; 1993 Apr; 16(3):234-6. PubMed ID: 8505497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niacin-induced hepatotoxicity: unusual presentations.
    Coppola A; Brady PG; Nord HJ
    South Med J; 1994 Jan; 87(1):30-2. PubMed ID: 8284714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant hepatic failure after ingestion of sustained-release nicotinic acid.
    Mullin GE; Greenson JK; Mitchell MC
    Ann Intern Med; 1989 Aug; 111(3):253-5. PubMed ID: 2665592
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatotoxicity associated with sustained-release niacin.
    Dalton TA; Berry RS
    Am J Med; 1992 Jul; 93(1):102-4. PubMed ID: 1626557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of niacin therapy that simulate neoplasia: hepatic steatosis with concurrent hepatic dysfunction.
    Kristensen T; Olcott EW
    J Comput Assist Tomogr; 1999; 23(2):314-7. PubMed ID: 10096345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hepatic failure associated with the use of low-dose sustained-release niacin.
    Hodis HN
    JAMA; 1990 Jul; 264(2):181. PubMed ID: 2355439
    [No Abstract]   [Full Text] [Related]  

  • 7. Rechallenge with crystalline niacin after drug-induced hepatitis from sustained-release niacin.
    Henkin Y; Johnson KC; Segrest JP
    JAMA; 1990 Jul; 264(2):241-3. PubMed ID: 2355446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic acid-induced fulminant hepatic failure.
    Clementz GL; Holmes AW
    J Clin Gastroenterol; 1987 Oct; 9(5):582-4. PubMed ID: 3680913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niacin-induced hepatitis: a potential side effect with low-dose time-release niacin.
    Etchason JA; Miller TD; Squires RW; Allison TG; Gau GT; Marttila JK; Kottke BA
    Mayo Clin Proc; 1991 Jan; 66(1):23-8. PubMed ID: 1988755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients.
    McKenney JM; Proctor JD; Harris S; Chinchili VM
    JAMA; 1994 Mar; 271(9):672-7. PubMed ID: 8309029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niacin revisited: clinical observations on an important but underutilized drug.
    Henkin Y; Oberman A; Hurst DC; Segrest JP
    Am J Med; 1991 Sep; 91(3):239-46. PubMed ID: 1892143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis caused by low-dose sustained-release niacin.
    Schwenk TL; Fisher M
    J Am Board Fam Pract; 1994; 7(3):242-4. PubMed ID: 8059629
    [No Abstract]   [Full Text] [Related]  

  • 13. Niacin induced coagulopathy as a manifestation of occult liver injury.
    Ali EH; McJunkin B; Jubelirer S; Hood W
    W V Med J; 2013; 109(1):12-4. PubMed ID: 23413541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonographic findings in niacin-induced hepatitis.
    Scheer MS; Perlmutter S; Ross W; Katz DS
    J Ultrasound Med; 1999 Apr; 18(4):321-3. PubMed ID: 10206223
    [No Abstract]   [Full Text] [Related]  

  • 15. Niacin. Help for your cholesterol--harm for your liver.
    Rourk RM; Rehman NU
    N C Med J; 1998; 59(2):87-8. PubMed ID: 9558894
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and side effects of sustained-release niacin.
    Lavie CJ; Milani RV
    JAMA; 1994 Aug; 272(7):513-4; author reply 514-5. PubMed ID: 8046796
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment: adverse-effect profile of sustained-release niacin.
    Jungnickel PW; Maloley PA
    DICP; 1991 Sep; 25(9):1014-5. PubMed ID: 1949965
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic toxicity of unmodified and time-release preparations of niacin.
    Rader JI; Calvert RJ; Hathcock JN
    Am J Med; 1992 Jan; 92(1):77-81. PubMed ID: 1731514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fulminant hepatic failure following low-dose sustained-release niacin therapy in hospital.
    Fischer DJ; Knight LL; Vestal RE
    West J Med; 1991 Oct; 155(4):410-2. PubMed ID: 1771885
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatotoxicity upon using niacin to pass a drug test: A case report.
    Durham SH; Covington EW; Clemmons KJ
    J Am Pharm Assoc (2003); 2018; 58(5):564-567. PubMed ID: 29941333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.